Azelnidipine plus olmesartan versus amlodipine plus olmesartan on arterial stiffness and cardiac function in hypertensive patients: A randomized trial

Drug Design, Development and Therapy

Volumn 7, Issue , 2013, Pages 175-183

  Takami, Takeshi ^a   Saito, Yoshihiko ^b  

^a Clinic Jingumae   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Arterial stiffness; Central blood pressure; Left ventricular diastolic function; Left ventricular mass index; Olmesartan azelnidipine

Indexed keywords

AMLODIPINE; AZELNIDIPINE; OLMESARTAN; AZETIDINE 2 CARBOXYLIC ACID; DIHYDROPYRIDINE DERIVATIVE; IMIDAZOLE DERIVATIVE; TETRAZOLE DERIVATIVE;

ADD ON THERAPY; AGED; ANKLE BRACHIAL INDEX; ARTERIAL STIFFNESS; ARTICLE; AUGMENTATION INDEX; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT OUTCOME; VERTIGO; ANALOGS AND DERIVATIVES; COMBINATION DRUG THERAPY; COMPARATIVE STUDY; DIASTOLE; DRUG EFFECTS; HEART RATE; HYPERTROPHY, LEFT VENTRICULAR; MIDDLE AGED; PATHOPHYSIOLOGY;

AGED; AMLODIPINE; AZETIDINECARBOXYLIC ACID; DIASTOLE; DIHYDROPYRIDINES; DRUG THERAPY, COMBINATION; FEMALE; HEART RATE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; IMIDAZOLES; MALE; MIDDLE AGED; PULSE WAVE ANALYSIS; TETRAZOLES; VASCULAR STIFFNESS; VENTRICULAR FUNCTION, LEFT;

EID: 84875465449     PISSN: 11778881     EISSN: None     Source Type: Journal    
DOI: 10.2147/DDDT.S42338     Document Type: Article

References (33)

1. Ogihara T, Kikuchi K, Matsuoka H, etal. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH2009). Hypertens Res. 2009;32:3-107.
2. Roman MJ, Devereux, Kizer JR, etal. Central pressure more strongly relates to vascular disease and outcome than dose brachial pressure: the Strong Heart Study. Hypertension. 2007;50:197-203.
3. Williams B, Lacy PS, Thom SM, et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduct Artery Function Evaluation (CAFE) study. Circulation. 2006;113:1213-1225.
4. Matsui Y, Eguchi K, O'Rourke MF, etal. Differential effects between a calcium channel blocker and a diuretic when used in combination with angiotensin II receptor blocker on central aortic pressure in hypertensive patients. Hypertension. 2009;54:716-723.
5. Takami T, Saito Y. Effects of azelnidipine plus olmesartan versus amlodipine plus olmesartan on central blood pressure and left ventricular mass index: the AORTA study. Vasc Health Risk Manag. 2011;7: 383-390.
6. Massie BM, Tubau JF, Szlachcic J, O'Kelly BF. Hypertensive heart disease: the critical role of left ventricular hypertrophy. J Cardiovasc Pharmacol. 1989;13(Suppl 1):S18-S24.
7. Bonow RO, Udelson JE. LV diastolic dysfunction as a cause of congestive heart failure. Mechanism and management. Ann Intern Med. 1992;117: 502-510.
8. Asmar R, Rudnichi A, Blacher J, London GM, Safar ME. Pulse pressure and aortic pulse wave are markers of cardiovascular risk in hypertensive populations. Am J Hypertens. 2001;14:91-97.
9. Laurent S, Boutouyrie P. Arterial stiffness and stroke in hypertension: therapeutic implications for stroke prevention. CNS Drugs. 2005;19: 1-11.
10. Blacher J, Safar ME. Large-artery stiffness, hypertension and cardiovascular risk in older patients. Nat Clin Pract Cardiovasc Med. 2005;2: 450-455.
11. Udelson JE, Konstam MA. Relation between left ventricular remodeling and clinical outcomes in heart failure patients with left ventricular systolic dysfunction. J Card Fail. 2002;8:S465-S471.
12. Wachtell K, Palmieri V, Gerdts E, et al. Prognostic significance of left ventricular diastolic dysfunction in patients with left ventricular hypertrophy and systemic hypertension (the LIFE Study). Am J Cardiol. 2010;106:999-1005.
13. Takazawa K, Kobayashi H, Shindo N, Tanaka N, Yamashina A. Relationship between radial and central arterial pulse wave and evaluation of central aortic pressure using the radial arterial pulse wave. Hypertens Res. 2007;30:219-228.
14. Richardson CJ, Maki-Petaja KM, McDonnell BJ, etal. Comparison of estimates of central systolic blood pressure and peripheral augmentation index obtained from the Omron HEM-9000AI and SphygmoCor systems. Artery Res. 2009;3:24-31.
15. Hickson SS, Butlin M, Mir FA, et al. The accuracy of central SBP determined from the second systolic peak of the peripheral pressure waveform. J Hypertens. 2009;27:1784-1788.
16. Hirata K, Kojima I, Momomura SI. Noninvasive estimation of central blood pressure and the augmentation index in the seated position: a validation study of two commercially available methods. J Hypertens. 2013;31:508-515.
17. Wilkinson IB, Mohammad NH, Tyrrell S, etal. Heart rate dependency of pulse pressure amplification and arterial stiffness. Am J Hypertens. 2002;15:24-30.
18. Devereux RB, Palmieri V, Sharpe N, et al. Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension: the prospective randomized enalapril study evaluating regression of ventricular enlargement (PRESERVE) trial. Circulation. 2001;104:1248-1254.
19. Safar ME, London GM. Therapeutic studies and arterial stiffness in hypertension: recommendations of the European Society of Hypertension. The Clinical Committee of Arterial Structure and Function. Working Group on Vascular Structure and Function of the European Society of Hypertension. J Hypertens. 2000;18:1527-1535.
20. Xu L, Jiang CQ, Lam TH, etal. Arterial stiffness and left-ventricular diastolic dysfunction: Guangzhou Biobank Cohort Study-CVD. J Hum Hypertens. 2011;25:152-158.
21. Kim MN, Park SM, Shim WJ, etal. The relationship between aortic stiffness and left ventricular dyssynchrony in hypertensive patients with preserved left ventricular systolic function. Clin Exp Hypertens. 2012;34:410-416.
22. Schillaci G, Pasqualini L, Verdecchia P, etal. Prognostic significance of left ventricular diastolic dysfunction in essential hypertension. J Am Coll Cardiol. 2002;39:2005-2011.
23. Ommen SR, Nishimura RA, Appleton CP, et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler-catheterization study. Circulation. 2000;102:1788-1794.
24. Hillis GS, Møller JE, Pellikka PA, etal. Noninvasive estimation of left ventricular filling pressure by e/e′ is a powerful predictor of survival after acute yocardial infarction. J Am Coll Cardiol. 2004;43:360-367.
25. Yambe M, Tomiyama H, Hirayama Y, et al. Arterial stiffening as a possible risk factor for both atherosclerosis and diastolic heart failure. Hypertens Res. 2004;27:625-631.
26. Jaroch J, Lstrok;oboz Grudzień K, Bociaga Z, etal. The relationship of carotid arterial stiffness to left ventricular diastolic dysfunction in untreated hypertension. Kardiol Pol. 2012;70:223-231.
27. Xu L, Jiang CQ, Lam TH, etal. Arterial stiffness and left-ventricular diastolic dysfunction: Guangzhou Biobank Cohort Study-CVD. J Hum Hypertens. 2011;25:152-158.
28. Reil JC, Hohl M, Reil GH, etal. Heart rate reduction by If-inhibition improves vascular stiffness and left ventricular systolic and diastolic function in a mouse model of heart failure with preserved ejection fraction. Eur Heart J. July 24, 2012. [Epub ahead of print.]
29. Fujisawa M, Yorikane R, Chiba S, Koike H. Chronotropic effects of azelnidipine, a slow and long-acting dihydropyridine-type calcium channel blocker, in anesthetized dogs: a comparison with amlodipine. J Cardiovasc Pharmacol. 2009;53:325-332.
30. Yamamoto E, Lai ZF, Yamashita T, etal. Enhancement of cardiac oxidative stress by tachycardia and its critical role in cardiac hypertrophy and fibrosis. J Hypertens. 2006;24:2057-2069.
31. Tomiyama H, Yamashina A. Arterial stiffness in prehypertension: a possible vicious cycle. J Cardiovasc Transl Res. 2012;5:280-286.
32. Ito H, Ishii K, Iwakura K. Impact of azelnidipine treatment on left ventricular diastolic performance in patients with hypertension and mild diastolic dysfunction: multi-center study with echocardiography. Hypertens Res. 2009;32:895-900.
33. Mottram PM, Haluska BA, Leano R, etal. Relation of arterial stiffness to diastolic dysfunction in hypertensive heart disease. Heart. 2005;91: 1551-1556.